WKL schreef op 1 maart 2026 20:26:
I took those last hours of the weekend to check on Open Evidence, and it seems like a couple more apps similar to it has emerged like the one attached in the picture.
And that they have been rejected for clinical administrators (I can imagine why! It's still just AI, and it has pharma influence because of ads). But Open Evidence is saying that this year they are trying to partner with more clinical associations to collect more data.
Bottom line everyone seems so far from UpToDate at least for a year ahead. And if the new CEO will deliver on improving the products even more this year, then I guess we are in a safe position.
So far the other chat-gpt like apps are nice sor personal use but not for big enterprise use. Just as it is in almost all sectors.